The renowned global medical device company has a market capitalization of $175.4 million. The company projects 9.9% growth over the next five years. Nevro’s earnings surpassed the Zacks ...

Analysts at StockNews.com initiated coverage on shares of Nevro (NYSE:NVRO – Get Free Report) in a research note issued on ...

Stay informed and make judicious decisions using our Ratings Table. Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its fourth-quarter and full-year ...

REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...

REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...

Nevro Corp . (NYSE:NVRO) reported fourth-quarter 2024 results that beat revenue expectations but showed a wider loss than analysts anticipated, as the medical device maker continues to face ...

Management uses certain non-GAAP financial measures, most specifically adjusted EBITDA, as a supplement to GAAP financial measures to further evaluate the Company's operating performance period ...